Medtronic Vascular recalls SHERPA NX ACTIVE GUIDING CATHETER models with potential for stainless-steel wire exposure. Affected units sold for cardiovascular procedures. Contact for return instructions.
There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.
Medtronic Vascular is recalling a specific type of cardiovascular catheter that could expose underlying steel wires, risking injury during procedures. This is a serious hazard for medical professionals using the device.
The catheter's primary segment material could break off, exposing thin stainless-steel wires. These wires might cause injury to blood vessels or tissue during medical procedures if not properly secured.
Healthcare professionals who use this catheter for cardiovascular procedures are most at risk. Patients receiving these procedures may also be affected if the catheter is used incorrectly.
Check for the model name SHERPA NX ACTIVE GUIDING CATHETER, 6F, HSI, 100CM, 070", REF SA6HSI. The product was sold for cardiovascular procedures with GTIN: 00613994824172.
Immediately stop using the recalled catheter as it poses a risk of wire exposure during procedures.
No, the recall states there is a potential for extensive loss of primary segment material exposing underlying steel wires, which could cause injury.
Check for the model name SHERPA NX ACTIVE GUIDING CATHETER, 6F, HSI, 100CM, 070", REF SA6HSI. The product was sold for cardiovascular procedures with GTIN: 00613994824172.
The recall does not specify a remedy, so contact Medtronic Vascular directly for instructions.
We’ve drafted a message you can send Medtr: a short, human brand name for headings (e.g. "Trsmima") to request your refund or repair — edit it as you like.
Subject: Recall Z-2581-2019 — Medtr: a short, human brand name for headings (e.g. "Trsmima") Medtr: a short, human brand name for Hello, I own a Medtr: a short, human brand name for headings (e.g. "Trsmima") that is covered by recall Z-2581-2019 from Medtr: a short, human brand name for headings (e.g. "Trsmima"). I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
